melatonin has been researched along with Behavior Disorder, Rapid Eye Movement Sleep in 39 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin is recommended as a first-line treatment in isolated REM sleep behavior disorder (iRBD), although no large patient group has been reported." | 8.02 | Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic. ( Bes, F; Kunz, D; Stotz, S, 2021) |
| "To evaluate changes in the expression of clock genes and melatonin levels in patients with idiopathic REM sleep behavior disorder (RBD) as a potential early stage of synucleinopathies." | 7.88 | Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder. ( Bartoš, A; Bendová, Z; Bušková, J; Červená, K; Dudysová, D; Kopřivová, J; Miletínová, E; Skálová, K; Škrabalová, J; Šonka, K; Weissová, K, 2018) |
| "Melatonin also has a favorable safety and tolerability profile over clonazepam with limited potential for drug-drug interactions, an important consideration especially in elderly individuals with RBD receiving polypharmacy." | 6.52 | Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. ( Boeve, BF; Leung, JG; McGrane, IR; St Louis, EK, 2015) |
| "Clonazepam has been the first-line therapy for many years, with 2 large case series reporting efficacy with few side effects in the majority of patients." | 5.35 | Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. ( Anderson, KN; Shneerson, JM, 2009) |
| "Clonazepam has been considered the treatment of choice for RBD." | 5.32 | Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. ( Boeve, BF; Ferman, TJ; Silber, MH, 2003) |
| "A MEDLINE search (1977-April 2007) using the terms REM sleep behavior disorder, narcolepsy, parkinsonian disorders, levodopa, dopamine agonists, clonazepam, benzodiazepines, and melatonin was used to retrieve relevant articles." | 4.84 | Rapid eye movement sleep behavior disorder. ( Gugger, JJ; Wagner, ML, 2007) |
| "Melatonin is recommended as a first-line treatment in isolated REM sleep behavior disorder (iRBD), although no large patient group has been reported." | 4.02 | Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic. ( Bes, F; Kunz, D; Stotz, S, 2021) |
| "To evaluate changes in the expression of clock genes and melatonin levels in patients with idiopathic REM sleep behavior disorder (RBD) as a potential early stage of synucleinopathies." | 3.88 | Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder. ( Bartoš, A; Bendová, Z; Bušková, J; Červená, K; Dudysová, D; Kopřivová, J; Miletínová, E; Skálová, K; Škrabalová, J; Šonka, K; Weissová, K, 2018) |
| "Melatonin and clonazepam were each reported to reduce RBD behaviors and injuries and appeared comparably effective in our naturalistic practice experience." | 3.79 | Treatment outcomes in REM sleep behavior disorder. ( Boeve, BF; Boswell, CL; Dueffert, LG; McCarter, SJ; Olson, EJ; Silber, MH; Slocumb, N; St Louis, EK; Tippmann-Peikert, M, 2013) |
| "Thirty PD patients with rapid eye movement sleep behavior disorder were randomized to 4 mg of prolonged-release melatonin (Circadin) or matched placebo, ingested orally once-daily before bedtime." | 2.94 | Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial. ( Coeytaux Jackson, A; Fang, BAM; Gilat, M; Grunstein, RR; Hall, JM; Hammond, D; Lewis, SJG; Marshall, NS; Mullins, AE; Wong, KKH; Yee, BJ, 2020) |
| " Switching to morning dosing or to an alternative drug may help." | 2.82 | [Sleep disorders in patients with a neurocognitive disorder]. ( Carrier, J; Dang-Vu, TT; Moderie, C, 2022) |
| "Patients with rapid eye movement sleep behavior disorder are frequently prone to sleep-related injuries and should be treated to prevent injury with either melatonin 3-12 mg or clonazepam 0." | 2.55 | REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies. ( Boeve, AR; Boeve, BF; St Louis, EK, 2017) |
| "Sleep disorders and neurodegenerative diseases are commonly encountered in primary care." | 2.53 | Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician. ( Howell, MJ; McCarter, SJ, 2016) |
| "Melatonin also has a favorable safety and tolerability profile over clonazepam with limited potential for drug-drug interactions, an important consideration especially in elderly individuals with RBD receiving polypharmacy." | 2.52 | Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. ( Boeve, BF; Leung, JG; McGrane, IR; St Louis, EK, 2015) |
| "Melatonin is a chronobiotic treatment which also alleviates rapid eye movement (REM) sleep behavior disorder (RBD)." | 1.43 | Loss of REM sleep features across nighttime in REM sleep behavior disorder. ( Arnaldi, D; Arnulf, I; Latimier, A; Leu-Semenescu, S; Vidailhet, M, 2016) |
| "To present a clinical case of idiopathic rapid eye movement sleep behavior disorder (RBD), differential diagnoses, selected treatments, and the pathology involved." | 1.36 | Making the diagnosis: idiopathic rapid eye movement sleep behavior disorder. ( Taub, LF, 2010) |
| "Clonazepam has been the first-line therapy for many years, with 2 large case series reporting efficacy with few side effects in the majority of patients." | 1.35 | Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. ( Anderson, KN; Shneerson, JM, 2009) |
| "Melatonin was successfully used as an alternative treatment." | 1.35 | REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease. ( Anderson, KN; Graham, AJ; Jamieson, S; Shneerson, JM, 2008) |
| "Clonazepam has been considered the treatment of choice for RBD." | 1.32 | Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. ( Boeve, BF; Ferman, TJ; Silber, MH, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (15.38) | 29.6817 |
| 2010's | 23 (58.97) | 24.3611 |
| 2020's | 10 (25.64) | 2.80 |
| Authors | Studies |
|---|---|
| Moderie, C | 1 |
| Carrier, J | 1 |
| Dang-Vu, TT | 1 |
| Byun, JI | 2 |
| Shin, YY | 1 |
| Seong, YA | 1 |
| Yoon, SM | 1 |
| Hwang, KJ | 1 |
| Jung, YJ | 1 |
| Cha, KS | 1 |
| Jung, KY | 2 |
| Shin, WC | 1 |
| Howell, M | 2 |
| Avidan, AY | 2 |
| Foldvary-Schaefer, N | 2 |
| Malkani, RG | 2 |
| During, EH | 3 |
| Roland, JP | 2 |
| McCarter, SJ | 5 |
| Zak, RS | 3 |
| Carandang, G | 2 |
| Kazmi, U | 2 |
| Ramar, K | 3 |
| Dodet, P | 1 |
| Miglis, MG | 1 |
| Gilat, M | 2 |
| Coeytaux Jackson, A | 1 |
| Marshall, NS | 2 |
| Hammond, D | 1 |
| Mullins, AE | 1 |
| Hall, JM | 1 |
| Fang, BAM | 1 |
| Yee, BJ | 1 |
| Wong, KKH | 1 |
| Grunstein, RR | 1 |
| Lewis, SJG | 3 |
| Du, Y | 1 |
| Jiang, J | 1 |
| Ng, CH | 1 |
| Wu, L | 1 |
| Zhang, P | 1 |
| Xi, C | 1 |
| Lai, J | 1 |
| Xu, Y | 1 |
| Hu, S | 1 |
| Wang, Z | 1 |
| Matar, E | 2 |
| St Louis, EK | 4 |
| Testelmans, D | 1 |
| Buyse, B | 1 |
| Iranzo, A | 3 |
| Ramos, LA | 1 |
| Novo, S | 1 |
| Kunz, D | 5 |
| Stotz, S | 1 |
| Bes, F | 3 |
| Boeve, AR | 1 |
| Boeve, BF | 5 |
| Schaefer, C | 1 |
| Lewis, SJ | 1 |
| Dauvilliers, Y | 2 |
| Schenck, CH | 3 |
| Postuma, RB | 1 |
| Luppi, PH | 2 |
| Plazzi, G | 2 |
| Montplaisir, J | 1 |
| Boeve, B | 1 |
| Weissová, K | 1 |
| Škrabalová, J | 1 |
| Skálová, K | 1 |
| Červená, K | 1 |
| Bendová, Z | 1 |
| Miletínová, E | 1 |
| Kopřivová, J | 1 |
| Šonka, K | 2 |
| Dudysová, D | 1 |
| Bartoš, A | 1 |
| Bušková, J | 1 |
| Jun, JS | 1 |
| Kim, R | 1 |
| Kim, TJ | 1 |
| Lim, JA | 1 |
| Sunwoo, JS | 1 |
| Lee, ST | 1 |
| Jung, KH | 1 |
| Park, KI | 1 |
| Chu, K | 1 |
| Kim, M | 1 |
| Lee, SK | 1 |
| Montplaisir, JY | 1 |
| Frauscher, B | 1 |
| Hogl, B | 1 |
| Gagnon, JF | 1 |
| Postuma, R | 1 |
| Jennum, P | 1 |
| Partinen, M | 2 |
| Arnulf, I | 2 |
| Cochen de Cock, V | 1 |
| Heidbreder, A | 1 |
| Mayer, G | 1 |
| Sixel-Döring, F | 1 |
| Trenkwalder, C | 1 |
| Unger, M | 1 |
| Young, P | 1 |
| Wing, YK | 1 |
| Ferini-Strambi, L | 1 |
| Ferri, R | 1 |
| Zucconi, M | 1 |
| Inoue, Y | 1 |
| Santamaria, J | 1 |
| Bassetti, C | 1 |
| Möller, JC | 1 |
| Lai, YY | 1 |
| Pavlova, M | 1 |
| Saper, C | 1 |
| Schmidt, P | 1 |
| Siegel, JM | 1 |
| Singer, C | 1 |
| St Louis, E | 1 |
| Videnovic, A | 1 |
| Oertel, W | 1 |
| McGrane, IR | 1 |
| Leung, JG | 1 |
| Arnaldi, D | 1 |
| Latimier, A | 1 |
| Leu-Semenescu, S | 1 |
| Vidailhet, M | 1 |
| Escribá, J | 1 |
| Hoyo, B | 1 |
| Howell, MJ | 2 |
| Pillai, JA | 1 |
| Leverenz, JB | 1 |
| Billiard, M | 1 |
| Anderson, KN | 2 |
| Shneerson, JM | 2 |
| Aurora, RN | 1 |
| Maganti, RK | 1 |
| Auerbach, SH | 1 |
| Casey, KR | 1 |
| Chowdhuri, S | 1 |
| Karippot, A | 1 |
| Kristo, DA | 1 |
| Morgenthaler, TI | 1 |
| Mahlberg, R | 1 |
| Taub, LF | 1 |
| Rizzi, DA | 1 |
| Brooks, PL | 1 |
| Peever, JH | 1 |
| Arneson, PA | 1 |
| Ylikoski, A | 1 |
| Boswell, CL | 1 |
| Dueffert, LG | 1 |
| Slocumb, N | 1 |
| Silber, MH | 2 |
| Olson, EJ | 1 |
| Tippmann-Peikert, M | 1 |
| Ferman, TJ | 1 |
| Gugger, JJ | 1 |
| Wagner, ML | 1 |
| Jamieson, S | 1 |
| Graham, AJ | 1 |
| Takeuchi, N | 1 |
| Uchimura, N | 1 |
| Hashizume, Y | 1 |
| Mukai, M | 1 |
| Etoh, Y | 1 |
| Yamamoto, K | 1 |
| Kotorii, T | 1 |
| Ohshima, H | 1 |
| Ohshima, M | 1 |
| Maeda, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Melatonin and Rivotril Treatment for Idiopathic Rapid Eye Movement Sleep Disorder: Prospective Randomized Study.[NCT03255642] | 34 participants (Actual) | Interventional | 2017-11-09 | Completed | |||
| A Randomized Double-Blind, Double-Dummy, Crossover Study to Evaluate the Efficacy and Safety of Prolonged-Release Melatonin and Clonazepam in Patients With Rapid Eye Movement (REM) Sleep Behavior Disorder in Parkinson Disease[NCT02789592] | Phase 2 | 30 participants (Anticipated) | Interventional | 2016-07-31 | Not yet recruiting | ||
| DREAMER - IsolateD REM Sleep Without Atonia as a Risk Factor for REM Sleep Behavior disordER: Constitution of a Cohort for a Long-term Prospective Follow-up Study[NCT06140511] | 600 participants (Anticipated) | Observational | 2023-11-20 | Not yet recruiting | |||
| A Single Center, Open Label Prospective Observational Pilot Study to Evaluate the Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)[NCT05922995] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2023-09-30 | Not yet recruiting | ||
| Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism: a Prospective, Randomized, Double-blind and Placebo-controlled Trial[NCT02312908] | Phase 2 | 40 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study[NCT02836743] | Phase 4 | 30 participants (Anticipated) | Interventional | 2016-01-31 | Recruiting | ||
| Efficacy and Tolerability of Ramelteon in Patients With REM Behavior Disorder and Parkinsonism: A Placebo Controlled, Double Blind, Randomized, Prospective Pilot Study[NCT00745030] | 3 participants (Actual) | Interventional | 2008-06-30 | Terminated (stopped due to Low subject recruitment and enrollment.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for melatonin and Behavior Disorder, Rapid Eye Movement Sleep
| Article | Year |
|---|---|
[Sleep disorders in patients with a neurocognitive disorder].
Topics: Alzheimer Disease; Chronobiology Disorders; Humans; Melatonin; REM Sleep Behavior Disorder; Restless | 2022 |
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United State | 2023 |
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United State | 2023 |
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United State | 2023 |
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United State | 2023 |
REM behavior disorder: When Parkinson's disease meets Morpheus.
Topics: Aged; Clonazepam; Humans; Melatonin; Parkinson Disease; REM Sleep Behavior Disorder; Synucleinopathi | 2023 |
Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.
Topics: Central Nervous System Depressants; Humans; Melatonin; REM Sleep Behavior Disorder; Treatment Outcom | 2021 |
A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials.
Topics: Aged; Clonazepam; Double-Blind Method; Humans; Melatonin; Randomized Controlled Trials as Topic; REM | 2022 |
The Isolated Form of Rapid Eye Movement Sleep Behavior Disorder: The Upcoming Challenges.
Topics: Clonazepam; Dementia; Diagnostic Tests, Routine; Humans; Melatonin; Parkinson Disease; REM Sleep Beh | 2021 |
REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.
Topics: Central Nervous System Depressants; Clonazepam; GABA Modulators; Humans; Lewy Body Disease; Melatoni | 2017 |
REM sleep behaviour disorder: not just a bad dream.
Topics: Clonazepam; Humans; Hypnotics and Sedatives; Melatonin; Polysomnography; REM Sleep Behavior Disorder | 2017 |
REM sleep behaviour disorder.
Topics: alpha-Synuclein; Antidepressive Agents; Central Nervous System Depressants; Clonazepam; Diagnosis, D | 2018 |
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
Topics: Central Nervous System Depressants; Humans; Melatonin; REM Sleep Behavior Disorder; Treatment Outcom | 2015 |
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
Topics: Central Nervous System Depressants; Humans; Melatonin; REM Sleep Behavior Disorder; Treatment Outcom | 2015 |
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
Topics: Central Nervous System Depressants; Humans; Melatonin; REM Sleep Behavior Disorder; Treatment Outcom | 2015 |
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
Topics: Central Nervous System Depressants; Humans; Melatonin; REM Sleep Behavior Disorder; Treatment Outcom | 2015 |
Importance of Rapid Eye Movement Sleep Behavior Disorder to the Primary Care Physician.
Topics: Central Nervous System Depressants; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Me | 2016 |
Sleep and Neurodegeneration: A Critical Appraisal.
Topics: Alzheimer Disease; Dementia; Humans; Lewy Body Disease; Melatonin; Multiple System Atrophy; Neurodeg | 2017 |
REM sleep behavior disorder and narcolepsy.
Topics: Antidepressive Agents; Cataplexy; Clonazepam; Humans; Melatonin; Narcolepsy; Polysomnography; Preval | 2009 |
[REM sleep behavior disorder (RBD)].
Topics: Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Melatonin; Parkinson Disease; Polysomn | 2012 |
Rapid eye movement sleep behavior disorder.
Topics: Anticonvulsants; Antiparkinson Agents; Benzothiazoles; Clonazepam; Comorbidity; Dopamine Agonists; G | 2007 |
3 trials available for melatonin and Behavior Disorder, Rapid Eye Movement Sleep
| Article | Year |
|---|---|
Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder.
Topics: Clonazepam; Humans; Melatonin; Polysomnography; Prospective Studies; REM Sleep Behavior Disorder | 2023 |
Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial.
Topics: Aged; Clonazepam; Double-Blind Method; Eye Movements; Fatigue; Female; Humans; Male; Melatonin; Midd | 2020 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.
Topics: Adult; Aged; Central Nervous System Depressants; Double-Blind Method; Humans; Male; Melatonin; Middl | 2010 |
21 other studies available for melatonin and Behavior Disorder, Rapid Eye Movement Sleep
| Article | Year |
|---|---|
Clinical trials in REM sleep behavior disorder: an urgent need for better evidence.
Topics: Aged; Anticonvulsants; Central Nervous System Depressants; Clinical Trials as Topic; Clonazepam; Fem | 2019 |
Vortioxetine improves rapid eye movement sleep behavior disorder: A case report.
Topics: Aged; Female; Humans; Melatonin; Polysomnography; REM Sleep Behavior Disorder; Treatment Outcome; Vo | 2020 |
Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic.
Topics: Humans; Melatonin; REM Sleep Behavior Disorder; Reproducibility of Results; Sleep, REM | 2021 |
Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series.
Topics: Aged; Humans; Hypnotics and Sedatives; Male; Melatonin; Polysomnography; REM Sleep Behavior Disorder | 2017 |
Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging.
Topics: Aged; Brain; Central Nervous System Depressants; Dopamine Plasma Membrane Transport Proteins; Humans | 2017 |
Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder.
Topics: Aged; ARNTL Transcription Factors; Circadian Rhythm; CLOCK Proteins; Gene Expression; Humans; Male; | 2018 |
Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder.
Topics: Adult; Double-Blind Method; Female; Hong Kong; Humans; Male; Melatonin; Middle Aged; Pilot Projects; | 2019 |
Melatonin in rapid eye movement sleep behavior disorder: why does it work?
Topics: Animals; Central Nervous System Depressants; Chronobiology Phenomena; Humans; Melatonin; REM Sleep B | 2013 |
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
Topics: Clinical Trials as Topic; Clonazepam; Consensus; GABA Modulators; Humans; Melatonin; Neuroprotective | 2013 |
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
Topics: Clinical Trials as Topic; Clonazepam; Consensus; GABA Modulators; Humans; Melatonin; Neuroprotective | 2013 |
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
Topics: Clinical Trials as Topic; Clonazepam; Consensus; GABA Modulators; Humans; Melatonin; Neuroprotective | 2013 |
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
Topics: Clinical Trials as Topic; Clonazepam; Consensus; GABA Modulators; Humans; Melatonin; Neuroprotective | 2013 |
Loss of REM sleep features across nighttime in REM sleep behavior disorder.
Topics: Adult; Aged; Chronobiology Disorders; Electromyography; Female; Humans; Male; Melatonin; Middle Aged | 2016 |
Alternatives to Clonazepam in REM Behavior Disorder Treatment.
Topics: Clonazepam; Humans; Melatonin; Polysomnography; REM Sleep Behavior Disorder | 2016 |
Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam.
Topics: Adjuvants, Anesthesia; Aged; Azabicyclo Compounds; Central Nervous System Depressants; Clonazepam; C | 2009 |
Best practice guide for the treatment of REM sleep behavior disorder (RBD).
Topics: Benzothiazoles; Central Nervous System Depressants; Clonazepam; Dopamine Agonists; GABA Modulators; | 2010 |
Making the diagnosis: idiopathic rapid eye movement sleep behavior disorder.
Topics: Aged; Anticonvulsants; Biomarkers; Central Nervous System Depressants; Clonazepam; Diagnosis, Differ | 2010 |
[Fighting with the Danish Medical Agency--core activity of the medical profession?].
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Denmark; Humans; | 2010 |
Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice.
Topics: Analysis of Variance; Animals; Brain; Central Nervous System Depressants; Clonazepam; Disease Models | 2011 |
A novel therapy for REM sleep behavior disorder (RBD).
Topics: Aged; Aged, 80 and over; Behavior Therapy; Clinical Alarms; Clonazepam; Drug Resistance; Female; Fol | 2011 |
Treatment outcomes in REM sleep behavior disorder.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Depressants; Clonazepam; Drug Therapy, Combin | 2013 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.
Topics: Adult; Aged; Clonazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resist | 2003 |
REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Diagnosis, Differential; Hormones; Humans; Male; Melatonin; Polysomnography | 2008 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |
Melatonin therapy for REM sleep behavior disorder.
Topics: Electromyography; Female; Humans; Male; Melatonin; Middle Aged; Polysomnography; REM Sleep Behavior | 2001 |